英文互译镜像站

3,4-Methylenedioxy-N-propargylamphetamine

Last updated
MDPL
MDPL.svg
Clinical data
Other names3,4-Methylenedioxy-N-propargylamphetamine; MDPL; N-Propargyl-MDA
Routes of
administration 		Oral [1]
ATC code
  • None
Pharmacokinetic data
Duration of action Unknown [1]
Identifiers
  • N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]prop-2-yn-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C13H15NO2
Molar mass 217.268 g·mol−1
3D model (JSmol)
  • CC(NCC#C)Cc1ccc2OCOc2c1
  • InChI=1S/C13H15NO2/c1-3-6-14-10(2)7-11-4-5-12-13(8-11)16-9-15-12/h1,4-5,8,10,14H,6-7,9H2,2H3
  • Key:LRYUTPIBTLEDJJ-UHFFFAOYSA-N

MDPL, also known as 3,4-methylenedioxy-N-propargylamphetamine or as N-propargyl-MDA, is a lesser-known drug and a substituted amphetamine. [1]

Contents

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDPL's minimum dose as 150 mg orally and its duration as unknown. [1] MDPL causes few to no effects. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPL. [1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act. [2]

See also

References

  1. 1 2 3 4 5 6 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN   0-9630096-0-5. OCLC   25627628. MDPL entry in PiHKAL
  2. ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
时间因子转换镜像 主动推送镜像站群 蚂蚁镜像站群 站点核心词加权 泛域名镜像